A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation

We studied the efficacy, safety and pharmacokinetic profiles of Intratect®, a recently developed polyvalent intravenous immunoglobulin (IVIG) preparation. Fifty-one patients (aged 6–48 years) with primary immunodeficiencies (PID) and established replacement therapy using a licensed IVIG were enrolle...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kreuz, W, Erdös, M, Rossi, P, Bernatowska, E, Espanol, T, Maródi, L
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2010
Matèries:
Translational Studies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2962969/
https://ncbi.nlm.nih.gov/pubmed/20550545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2010.04187.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars